Mesenchymal stromal cells in human immunodeficiency virus‐infected patients with discordant immune response: Early results of a phase I/II clinical trial - Trujillo‐Rodríguez, María; Viciana, Pompeyo; Rivas‐Jeremías, Inmaculada; Álvarez‐Ríos, Ana I.; Ruiz‐García, Antonio; Espinosa‐Ibáñez, Olga; Arias‐Santiago, Salvador; Martínez‐Atienza, Juliana; Mata, Rosario; Fernández‐López, Olga; Ruiz‐Mateos, Ezequiel; Gutiérrez‐Valencia, Alicia; et al. (Stem cells translational medicine, 2021)
Keywords: Acquired immune deficiency syndrome; Adipose tissue; AIDS; Antiretroviral drugs; CD4 antigen; CD8 antigen; clinical trial; Clinical trials; Dendritic cells; Drug therapy; Hepatitis; HIV; HIV infection; Hospitals; Human Clinical; Human immunodeficiency virus; Immune response; immunological nonresponders; Immunology; Immunoregulation; Infections; Inflammation; Leukocytes (mononuclear); Lymphocytes; Lymphocytes T; Mesenchymal stem cells; mesenchymal stromal cells; Mesenchyme; Morbidity; Natural killer cells; Patients; Peripheral blood mononuclear cells; Phenotypes; Stromal cells; Thrombosis; clinical trial; immunological nonresponders; HIV infection; mesenchymal stromal cells